Kalydeco – A Cystic Fibrosis Treatment
Originally posted in Cystic Fibrosis News From Medical News Today
Kalydeco has been approved by the Food And Drug Administration (FDA) to treat a vicious type of Cystic Fibrosis (CF). CF is a deadly recessive disease which targets the lungs, but can also harm the liver, pancreas, and intestine. It occurs from the unusual transport of chloride and sodium across the epithelium, causing mucus buildup in the lungs, and thick secretions…
No Comments »
RSS feed for comments on this post. TrackBack URL
by Raelene
